Page last updated: 2024-11-07

1-(1-phenylcyclohexyl)-3-methylpiperidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-(1-phenylcyclohexyl)-3-methylpiperidine: RN given refers to cpd without isomeric designation 7/29/83 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID150980
CHEMBL ID42842
SCHEMBL ID5674113
MeSH IDM0111339

Synonyms (10)

Synonym
pcmp
CHEMBL42842 ,
3-methyl-1-(1-phenylcyclohexyl)piperidine
bdbm50018929
3-methyl-1-(1-phenyl-cyclohexyl)-piperidine
2201-41-4
1-(1-phenylcyclohexyl)-3-methylpiperidine
piperidine, 3-methyl-1-(1-phenylcyclohexyl)-
SCHEMBL5674113
DTXSID20944619

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response curves for induction of behavior was very different from that for increasing the concentration of i beta-E in plasma."( Phencyclidine increased release of beta-endorphin from anterior lobe of the pituitary.
Contreras, PC; Farah, JM; Jacobson, AE; Rice, KC, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID157591Binding affinity against phencyclidine receptor was determined by the displacement of [3H]TCP of whole rat brain minus cerebellum.1988Journal of medicinal chemistry, Aug, Volume: 31, Issue:8
Synthesis, pharmacological action, and receptor binding affinity of the enantiomeric 1-(1-phenyl-3-methylcyclohexyl)piperidines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (73.68)18.7374
1990's5 (26.32)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.33 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]